Literature DB >> 19959700

Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load.

Long Fu Xi1, Laura A Koutsky, Philip E Castle, Zoe R Edelstein, Craig Meyers, Jesse Ho, Mark Schiffman.   

Abstract

BACKGROUND: Although cigarette smoking has been associated with increased human papilloma virus (HPV) detection, its impact on HPV DNA load is unknown.
METHODS: The study subjects were women who were positive for HPV16 and/or HPV18 at enrollment into the Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study. Assessments of exposure to smoke and sexual behavior were based on self-report. Viral genome copies per nanogram of cellular DNA were measured by multiplex real-time PCR. Linear or logistic regression models were used to assess the relationship between cigarette smoking and baseline viral load.
RESULTS: Of the 1,050 women (752 with HPV16, 258 with HPV18, and 40 with both HPV16 and HPV18), 452 (43.0%) were current smokers and 101 (9.6%) were former smokers at enrollment. The baseline viral load was statistically significantly greater for current compared with never smokers (P = 0.03 for HPV16; P = 0.02 for HPV18) but not for former smokers. Among current smokers, neither HPV16 nor HPV18 DNA load seemed to vary appreciably by age at smoking initiation, smoking intensity, or smoking duration. The results remained similar when the analysis of smoking-related HPV16 DNA load was restricted to women without detectable cervical abnormality.
CONCLUSION: Higher baseline HPV16 and HPV18 DNA load was associated with status as a current but not former smoker. A lack of dose-response relationship between cigarette smoking and viral load may indicate a low threshold for the effect of smoking on HPV DNA load.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19959700      PMCID: PMC2920639          DOI: 10.1158/1055-9965.EPI-09-0763

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  52 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry.

Authors:  A A Melikian; P Sun; B Prokopczyk; K El-Bayoumy; D Hoffmann; X Wang; S Waggoner
Journal:  Cancer Lett       Date:  1999-11-15       Impact factor: 8.679

3.  Effects of cigarette smoke on immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP3-sensitive Ca(2+) stores.

Authors:  R Kalra; S P Singh; S M Savage; G L Finch; M L Sopori
Journal:  J Pharmacol Exp Ther       Date:  2000-04       Impact factor: 4.030

4.  Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women.

Authors:  Jill Koshiol; Jane Schroeder; Denise J Jamieson; Stephen W Marshall; Ann Duerr; Charles M Heilig; Keerti V Shah; Robert S Klein; Susan Cu-Uvin; Paula Schuman; David Celentano; Jennifer S Smith
Journal:  Am J Epidemiol       Date:  2006-06-14       Impact factor: 4.897

5.  Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development.

Authors:  Anthony S Gunnell; Trung N Tran; Anna Torrång; Paul W Dickman; Pär Sparén; Juni Palmgren; Nathalie Ylitalo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-10-20       Impact factor: 4.254

6.  The role of smoking and alcohol intake in the development of high-grade squamous intraepithelial lesions among high-risk HPV-positive women.

Authors:  Janne Tolstrup; Christian Munk; Birthe Lykke Thomsen; Edith Svare; Adriaan J C van den Brule; Morten Grønbaek; Chris Meijer; Susanne Kjaer Krüger
Journal:  Acta Obstet Gynecol Scand       Date:  2006       Impact factor: 3.636

7.  The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis.

Authors:  Samina Alam; Michael J Conway; Horng-Shen Chen; Craig Meyers
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

8.  Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection.

Authors:  Aline Simen-Kapeu; Vesa Kataja; Merja Yliskoski; Kari Syrjänen; Joakim Dillner; Pentti Koskela; Jorma Paavonen; Matti Lehtinen
Journal:  Scand J Infect Dis       Date:  2008

9.  Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys.

Authors:  Salvatore Vaccarella; Rolando Herrero; Peter J F Snijders; Min Dai; Jaiye O Thomas; Nguyen Trong Hieu; Catterina Ferreccio; Elena Matos; Hector Posso; Silvia de Sanjosé; Hai Rim Shin; Sukhon Sukvirach; Eduardo Lazcano-Ponce; Nubia Muñoz; Chris J L M Meijer; Silvia Franceschi
Journal:  Int J Epidemiol       Date:  2008-03-03       Impact factor: 7.196

10.  Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade CIN.

Authors:  Kari Syrjänen; Irena Shabalova; Nicolay Petrovichev; Vladimir Kozachenko; Tatjana Zakharova; Julia Pajanidi; Jurij Podistov; Galina Chemeris; Larisa Sozaeva; Elena Lipova; Irena Tsidaeva; Olga Ivanchenko; Alla Pshepurko; Sergej Zakharenko; Raisa Nerovjna; Ludmila Kljukina; Oksana Erokhina; Marina Branovskaja; Maritta Nikitina; Valerija Grunberga; Alexandr Grunberg; Anna Juschenko; Rosa Santopietro; Marcella Cintorino; Piero Tosi; Stina Syrjänen
Journal:  Eur J Epidemiol       Date:  2007-09-08       Impact factor: 12.434

View more
  31 in total

1.  Smoking and human papillomavirus (HPV) infection in the HPV in Men (HIM) study.

Authors:  Matthew B Schabath; Luisa L Villa; Eduardo Lazcano-Ponce; Jorge Salmerón; Manuel Quiterio; Anna R Giuliano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10-20       Impact factor: 4.254

2.  Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes.

Authors:  Lanlan Wei; Anastacia M Griego; Ming Chu; Michelle A Ozbun
Journal:  Carcinogenesis       Date:  2014-07-26       Impact factor: 4.944

3.  Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly.

Authors:  Tsung-chieh Jane Fu; Long Fu Xi; Ayaka Hulbert; James P Hughes; Qinghua Feng; Stephen M Schwartz; Stephen E Hawes; Laura A Koutsky; Rachel L Winer
Journal:  Int J Cancer       Date:  2015-05-29       Impact factor: 7.396

Review 4.  Human papillomavirus: what every provider should know.

Authors:  Britt K Erickson; Ronald D Alvarez; Warner K Huh
Journal:  Am J Obstet Gynecol       Date:  2012-09-14       Impact factor: 8.661

5.  Treatment of a human papillomavirus type 31b-positive cell line with benzo[a]pyrene increases viral titer through activation of the Erk1/2 signaling pathway.

Authors:  Brian S Bowser; Samina Alam; Craig Meyers
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

6.  Downregulation of Cdc2/CDK1 kinase activity induces the synthesis of noninfectious human papillomavirus type 31b virions in organotypic tissues exposed to benzo[a]pyrene.

Authors:  Samina Alam; Brian S Bowser; Michael J Conway; Mohd Israr; Eric J Ryndock; Long Fu Xi; Craig Meyers
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

7.  Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease.

Authors:  Anil K Chaturvedi; Hormuzd A Katki; Allan Hildesheim; Ana Cecilia Rodríguez; Wim Quint; Mark Schiffman; Leen-Jan Van Doorn; Carolina Porras; Sholom Wacholder; Paula Gonzalez; Mark E Sherman; Rolando Herrero
Journal:  J Infect Dis       Date:  2011-04-01       Impact factor: 5.226

8.  Oral and genital HPV genotypic concordance between sexual partners.

Authors:  Camila Maria Beder Ribeiro; Iracema Ferrer; Andreza Barkokebas Santos de Farias; Débora Diniz Fonseca; Igor Henrique Morais Silva; Luiz Alcino Monteiro Gueiros; Alessandra Tavares Carvalho; Stephen Ross Porter; Jair Carneiro Leao
Journal:  Clin Oral Investig       Date:  2013-03-14       Impact factor: 3.573

9.  Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.

Authors:  Jessica A Kahn; Bret J Rudy; Jiahong Xu; Bill Kapogiannis; Elizabeth Secord; Maura Gillison
Journal:  J Med Virol       Date:  2016-05-09       Impact factor: 2.327

10.  Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.

Authors:  Frederico O Gleber-Netto; Mei Zhao; Sanchit Trivedi; Jiping Wang; Samar Jasser; Christina McDowell; Humam Kadara; Jiexin Zhang; Jing Wang; William N William; J Jack Lee; Minh Ly Nguyen; Sara I Pai; Heather M Walline; Dong M Shin; Robert L Ferris; Thomas E Carey; Jeffrey N Myers; Curtis R Pickering
Journal:  Cancer       Date:  2017-10-20       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.